These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 26041964)

  • 1. Management of overt hepatic encephalopathy.
    Sharma P; Sharma BC
    J Clin Exp Hepatol; 2015 Mar; 5(Suppl 1):S82-7. PubMed ID: 26041964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disaccharides in the treatment of hepatic encephalopathy.
    Sharma P; Sharma BC
    Metab Brain Dis; 2013 Jun; 28(2):313-20. PubMed ID: 23456517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for hepatic encephalopathy.
    Phongsamran PV; Kim JW; Cupo Abbott J; Rosenblatt A
    Drugs; 2010 Jun; 70(9):1131-48. PubMed ID: 20518580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
    Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic encephalopathy - recent advances in treatment and diagnosis.
    Nardelli S; Gioia S; Faccioli J; Riggio O; Ridola L
    Expert Rev Gastroenterol Hepatol; 2023 Mar; 17(3):225-235. PubMed ID: 36843291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hepatic encephalopathy in the hospital.
    Leise MD; Poterucha JJ; Kamath PS; Kim WR
    Mayo Clin Proc; 2014 Feb; 89(2):241-53. PubMed ID: 24411831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic Encephalopathy: Diagnosis and Management.
    Ridola L; Faccioli J; Nardelli S; Gioia S; Riggio O
    J Transl Int Med; 2020 Dec; 8(4):210-219. PubMed ID: 33511048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL; Vilstrup H; Morgan MY
    Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis.
    Moran S; López-Sánchez M; Milke-García MDP; Rodríguez-Leal G
    World J Gastroenterol; 2021 Jun; 27(22):3050-3063. PubMed ID: 34168407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary prevention of hepatic encephalopathy post-TIPS: A systematic review and meta-analysis.
    Liang A; Brar S; Almaghrabi M; Khan MQ; Qumosani K; Teriaky A
    Medicine (Baltimore); 2023 Sep; 102(38):e35266. PubMed ID: 37746955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management Patterns of Hepatic Encephalopathy: A Nationwide Survey in India.
    Sharma P; Sharma BC
    J Clin Exp Hepatol; 2015 Sep; 5(3):199-203. PubMed ID: 26628837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy for the treatment and prevention of hepatic encephalopathy.
    Mohammad RA; Regal RE; Alaniz C
    Ann Pharmacother; 2012 Nov; 46(11):1559-63. PubMed ID: 23092866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Variable Treatment Options in the Prevention of Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis.
    Hammd M; Elghezewi A; Abdulhadi A; Alabid A; Alabid A; Badi Y; Kamal I; Hesham Gamal M; Mohamed Fisal K; Mujtaba M; Sherif A; Frandah W
    Cureus; 2024 Jan; 16(1):e53341. PubMed ID: 38435950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?
    Gluud LL; Dam G; Borre M; Les I; Cordoba J; Marchesini G; Aagaard NK; Vilstrup H
    Metab Brain Dis; 2013 Jun; 28(2):221-5. PubMed ID: 23275147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis.
    Dhiman RK; Thumburu KK; Verma N; Chopra M; Rathi S; Dutta U; Singal AK; Taneja S; Duseja A; Singh M
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):800-812.e25. PubMed ID: 31476436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current trends in the treatment of hepatic encephalopathy.
    Al Sibae MR; McGuire BM
    Ther Clin Risk Manag; 2009 Jun; 5(3):617-26. PubMed ID: 19707277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of hepatic encephalopathy: current and future drug targets.
    Maharshi S; Sharma BC
    Hepatol Int; 2024 Aug; 18(4):1096-1109. PubMed ID: 38492132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Efficacy of Treatment Options for the Prevention of Post-TIPS Hepatic Encephalopathy: A Systematic Review and Network Meta-analysis.
    Ahmed Z; Hassan M; Arif SF; Aziz M; Iqbal U; Nawaz A; Farooq U; Smith WL; Badal J; Renno A; Javaid T; Nawras A; Saab S
    J Gastrointestin Liver Dis; 2023 Apr; 32(1):70-76. PubMed ID: 37004220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
    Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
    Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.